CIK 0001649904
- Large accelerated filer
RHYTHM PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- RYTM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 462159271
- Phone
- +1 857-264-4280
- Business address
- 222 BERKELEY STREET, 12TH FLOOR, BOSTON, MA, 02116
- Former names
- RHYTHM METABOLIC, INC.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $11,753,355
- in 2 filings, $11.8M under 10b5-1 plans
Net −$11,753,355. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-08-13 | Lee Jennifer Kayden EVP, Head of North America | Exercise or conversion 10b5-1 | +35,000 | $24.29 | $850K | 54,233 |
| 2026-08-13 | Lee Jennifer Kayden EVP, Head of North America | Exercise or conversion 10b5-1 | +21,601 | $6.80 | $147K | 75,834 |
| 2026-08-13 | Lee Jennifer Kayden EVP, Head of North America | Sale 10b5-1 | −75,834 | $117.38 | $8.9M | 0 |
| 2026-08-13 | Lee Jennifer Kayden EVP, Head of North America | Exercise or conversion · Stock Options (Right to Buy) 10b5-1 | −35,000 | 36,283 | ||
| 2026-08-13 | Lee Jennifer Kayden EVP, Head of North America | Exercise or conversion · Stock Options (Right to Buy) 10b5-1 | −21,601 | 0 | ||
| 2026-02-11 | Lee Jennifer Kayden EVP, Head of North America | Grant or award · Restricted Stock Units | +21,650 | 21,650 | ||
| 2026-02-11 | Lee Jennifer Kayden EVP, Head of North America | Grant or award · Stock Options (Right to Buy) | +32,500 | 32,500 | ||
| 2026-02-01 | Lee Jennifer Kayden EVP, Head of North America | Exercise or conversion | +22,612 | 28,470 | ||
| 2026-02-01 | Lee Jennifer Kayden EVP, Head of North America | Shares withheld for taxes | −9,237 | $108.99 | $1.0M | 19,233 |
| 2026-02-01 | Lee Jennifer Kayden EVP, Head of North America | Exercise or conversion · Restricted Stock Units | −3,437 | 0 | ||
| 2026-02-01 | Lee Jennifer Kayden EVP, Head of North America | Exercise or conversion · Restricted Stock Units | −4,512 | 4,512 | ||
| 2026-02-01 | Lee Jennifer Kayden EVP, Head of North America | Exercise or conversion · Restricted Stock Units | −5,500 | 11,000 | ||
| 2026-02-01 | Lee Jennifer Kayden EVP, Head of North America | Exercise or conversion · Restricted Stock Units | −9,163 | 27,487 | ||
| 2025-02-19 | Lee Jennifer Kayden EVP, Head of North America | Sale 10b5-1 | −2,035 | $57.22 | $116K | 5,858 |
| 2025-02-16 | Lee Jennifer Kayden EVP, Head of North America | Exercise or conversion 10b5-1 | +5,500 | 7,893 | ||
| 2025-02-16 | Lee Jennifer Kayden EVP, Head of North America | Exercise or conversion · Restricted Stock Units 10b5-1 | −5,500 | 16,500 | ||
| 2025-02-14 | Lee Jennifer Kayden EVP, Head of North America | Grant or award · Restricted Stock Units 10b5-1 | +36,650 | 36,650 | ||
| 2025-02-14 | Lee Jennifer Kayden EVP, Head of North America | Grant or award · Stock Options (Right to Buy) 10b5-1 | +55,000 | 55,000 | ||
| 2025-02-13 | Lee Jennifer Kayden EVP, Head of North America | Sale 10b5-1 | −1,205 | $58.00 | $70K | 2,393 |
| 2025-02-12 | Lee Jennifer Kayden EVP, Head of North America | Sale 10b5-1 | −600 | $56.39 | $34K | 4,813 |
Page 1 of 5 · 86 trades